Source: Annual Congress 2005 - Lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dworakowska, E. Jassem, J. Jassem, R. Schneider-Stock, C. Boltze, K. H. Wiedorn, J. Skokowski, K. Jaskiewicz, E. Czestochowska (Gdansk, Poland; Magdeburg, Stuttgart, Germany). MDM2 gene amplification and mdm2 protein expression in NSCLC cells. Eur Respir J 2005; 26: Suppl. 49, 665

Member's Comments

No comment yet.

Related content which might interest you: Expression of survivin and p53 protein in pulmonary tumours Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 Studies on clinical significance and relationship with PI and gene protein expression of p16, Rb and Cyclin-D1 in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Apoptosis regulatory protein (p53, Bcl-2, survivin) expression in lung cancer-preliminary study Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Simultaneous assessment of p21/waf1, p53, pRb, mdm2 and cyclin D1in NSCLC cells Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005 Benzo[a]pyrene increase ubiquitination of p21 protein following the stabilization of p53 and the expression of p21 Source: Eur Respir J 2002; 20: Suppl. 38, 482s Year: 2002 The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003 Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 Correlation between expression of p53, pRb, mdm2, p21WAF1/CIP1, PCNA, cyclin D1 and apoptotic index (AI) in non-small cell lung cancer (NSCLC) cells Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006 Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth in vivo by retrovirus-mediated gene transfer Source: Annual Congress 2002 - Thoracic oncology: biology Year: 2002 Expression of p53, Bcl-2 and Bax in non-small cell lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 512s Year: 2007 c-erbB-1 and c-erbB-2 receptors genetic abnormalities and protein expression in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 705s Year: 2004 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002 Prognostic significance and correlation between Akt phosphorylation and loss of PTEN protein expression in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Aberrant methylation of p16 tumour suppresor gene and DAP kinase in nonsmall cell lung carcinomas Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006